Document Detail

Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller.
MedLine Citation:
PMID:  18503896     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To describe restenosis and clinical outcomes with drug-eluting stents (DESs) and compare them to those of bare metal stents (BMSs) in the treatment of symptomatic atherosclerotic renal artery stenosis (RAS) in the same patients. METHODS AND MATERIALS: A retrospective study was performed of all patients with RAS treated with a DES (Taxus Express 2 or Cypher). DESs were used for RASs with luminal vessel diameters of 4 mm or smaller and BMSs were used for those larger than 4 mm. RESULTS: Sixteen patients (eight women; mean age, 72 years +/- 8) underwent treatment of 27 RASs for worsening renal function (n = 10) and uncontrolled hypertension (n = 6). Eighteen RASs were treated with 23 DESs (Cypher, n = 12; Taxus, n = 11) and nine were treated with BMSs. The average follow-up was 22 months +/- 10. After the procedure, the mean systolic blood pressure decreased significantly (P < .05), with no change in the mean diastolic pressure, serum creatinine, or number of antihypertensive medications. By Kaplan-Meier estimates, the 1- and 2-year patency rates for DESs were 78% and 68%, respectively; and for BMSs, the respective rates were 58% and 47% (P = NS). The average diameters of RASs were 3.4 mm +/- 0.6 in the DES group and 5.3 mm +/- 0.6 in the BMS group (P < .05). There were two technical failures (7.7%) in the DES group. There was one minor complication and a non-flow-limiting dissection. CONCLUSIONS: DESs were used to treat RASs with good technical results and low restenosis rates compared with BMSs despite the smaller artery diameters in the DES group.
Sanjay Misra; Mallik R Thatipelli; Patrick W Howe; Christopher Hunt; Verghese Mathew; Gregory W Barsness; Axel Pflueger; Stephen C Textor; Haraldur Bjarnason; Michael A McKusick
Related Documents :
20459456 - Rotablation in the drug eluting era: immediate and long-term results from a single cent...
17053006 - Intracoronary infusion of progenitor cells is not associated with aggravated restenosis...
22953636 - Chronic constipation in hypercalcemic patients with primary hyperparathyroidism.
22064606 - The safety and efficacy of etanercept on cardiac functions and lipid profile in patient...
23029966 - Effect of yoga practices on pulmonary function tests including transfer factor of lung ...
9060046 - Melioidosis; a treatment challenge.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-04-28
Journal Detail:
Title:  Journal of vascular and interventional radiology : JVIR     Volume:  19     ISSN:  1051-0443     ISO Abbreviation:  J Vasc Interv Radiol     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-27     Completed Date:  2008-10-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203369     Medline TA:  J Vasc Interv Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  833-9     Citation Subset:  IM    
Department of Radiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Alfred 6460, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Drug-Eluting Stents*
Gadolinium DTPA / diagnostic use
Immunosuppressive Agents / administration & dosage*
Middle Aged
Paclitaxel / administration & dosage*
Proportional Hazards Models
Renal Artery Obstruction / drug therapy*,  radiography,  ultrasonography
Retrospective Studies
Sirolimus / administration & dosage*
Treatment Outcome
Tubulin Modulators / administration & dosage*
Vascular Resistance
Reg. No./Substance:
0/Immunosuppressive Agents; 0/Tubulin Modulators; 33069-62-4/Paclitaxel; 53123-88-9/Sirolimus; 80529-93-7/Gadolinium DTPA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis plac...
Next Document:  Evaluation of short-term and long-term complications after emergent internal iliac artery embolizati...